Evolving Past Alzheimer's

Why I'm excited about Aducanumab (Aduhelm)!

07.28.2021 - By Evolving Past Alzheimer'sPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. Nate Bergman quickly summarizes the story up the FDA's recent "accelerated approval" of Biogen's - Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval...and it's probably not what you think! A quick, but useful listen.   In this episode we talk about… The terms of the approval of the drug What Aducanumab was able to accomplish in Alzheimer's patients The circumstances that led to Aducanumab being approved Some of the problems that arise with Aducanumab Why I am excited about Aducanumab

More episodes from Evolving Past Alzheimer's